Global Health and Life Sciences newsletter - Edition 10 | Health and Life Sciences | Eversheds Sutherland
Global Health and Life Sciences newsletter - Edition 10
Updates in a heartbeat
August 12, 2024
Global
Global
Global
Welcome to the latest edition of “Updates in a heartbeat”. Our newsletter provides you with a compilation of key legal developments over the last few months.
Regulatory reform of the sector remains a key priority of governments around the world. China’s state council has issued plans for wide ranging reform of the country’s medical and healthcare sector including changes to the drug review and approval system and improved monitoring of drug supply security. There are also more specialist updates from across Europe including changes to the medical devices system in Portugal and various reforms to the food and supplement regulatory regime in Poland and the Czech Republic. Another key area of activity is in relation to product liability law where important changes are planned for Poland and China. We also report on various updates on clinical trial investigations as well as ongoing policy debates on AI in the UK.
We hope you enjoy our latest newsletter and please do reach out to us if you would like to discuss any of the issues in more detail.
The materials on the Eversheds Sutherland website are for general information purposes only and do not constitute legal advice. While reasonable care is taken to ensure accuracy, the materials may not reflect the most current legal developments. Eversheds Sutherland disclaims liability for actions taken based on the materials. Always consult a qualified lawyer for specific legal matters. To view the full disclaimer, see our Terms and Conditions or Disclaimer section in the footer. Eversheds Sutherland is a provider of legal and other services operating through various separate and distinct legal entities. For further information about these entities and Eversheds Sutherlands' structure please see the Legal Notice page of this website.